How the body's internal (circadian) clock controls metabolism and health

Molecular mechanisms of mammalian circadian clock function - Renewal - 1

NIH-funded research Ut Southwestern Medical Center · NIH-11180129

This research looks at how the body's internal clock controls daily rhythms in metabolism and how that affects conditions like obesity, diabetes, heart disease, and cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-11180129 on NIH RePORTER

What this research studies

Researchers study the molecular parts of the circadian clock — proteins such as CLOCK, BMAL1, PER, CRY, and genes like Nocturnin — mainly using lab models and tissue samples to see how they drive daily gene and metabolic rhythms. They alter clock genes and measure changes in gene activity, biochemistry, weight, cholesterol, and behavior across daily cycles. The work aims to link clock disruption to metabolic problems and disease, and to point to biological targets that could be useful for future patient treatments.

Who could benefit from this research

Good fit: People with disrupted sleep schedules or circadian disruption (for example shift workers or people with chronic jet lag) and those with obesity, diabetes, or cardiovascular disease are most likely to benefit from findings in the future.

Not a fit: Patients seeking an immediate new treatment should not expect direct benefit from this basic lab-focused research, since it mainly uses models and tissue studies rather than testing therapies in people now.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or treat metabolic, cardiovascular, and cancer risks that are tied to disrupted sleep and daily rhythms.

How similar studies have performed: Animal and cell studies have already shown that changing clock genes can alter metabolism and weight, but turning those findings into human treatments is still early.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions CancersCardiovascular Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.